Testing effectiveness (Phase 2)Active Not RecruitingNCT06736717
What this trial is testing
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
Who this might be right for
Pancreatic Cancer
University of Kansas Medical Center 16